Skip to Content
Merck
CN
  • The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.

The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.

Bioorganic & medicinal chemistry (2007-05-29)
Cláudia Valente, Rui Moreira, Rita C Guedes, Jim Iley, Mohammed Jaffar, Kenneth T Douglas
ABSTRACT

A series of 1,4-naphthoquinone derivatives diversely substituted at C-2, C-3, C-5 and C-8, prepared by reaction of amines, amino acids and alcohols with commercial 1,4-naphthoquinones, has been evaluated against papain and bovine spleen cathepsin B. These 1,4-naphthoquinone derivatives were found to be irreversible inhibitors for both cysteine proteases, with second-order rate constants, k(2), ranging from 0.67 to 35.4M(-1)s(-1) for papain, and from 0.54 to 8.03M(-1)s(-1) for cathepsin B. Some derivatives display a hyperbolic dependence of the first-order inactivation rate constant, k(obs), with the inhibitor concentration, indicative of a specific interaction process between enzyme and inhibitor. The chemical reactivity of the compounds towards cysteine as a model thiol is dependent on the naphthoquinone LUMO energy, whereas papain inactivation is not. The 1,4-naphthoquinone derivatives are inactive against the serine protease, porcine pancreatic elastase.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1,4-Naphthoquinone, purum, ≥96.5% (HPLC)
Sigma-Aldrich
5-Hydroxy-1,4-naphthoquinone, 97%
Sigma-Aldrich
1,4-Naphthoquinone, 97%
Supelco
Menadione (K3), analytical standard
Sigma-Aldrich
Menadione, crystalline
Sigma-Aldrich
Menadione, meets USP testing specifications